Their research emphasized the complement pathway and interactions between β-actin (ACTB) and profilin-1 (PFN1) and endothelial nitric oxide synthase type 3 (eNOS or NOS-3), as possible indicators of the pathophysiology of FD. Here, PFN1 is linked to Fabry disease.